CLASS II Device recall · Reported 23 Jan 2019 · FDA Enforcement Report

Premier Cryptococcal Antigen recalled by Meridian Bioscience

Meridian Bioscience is recalling Premier Cryptococcal Antigen, distributed nationwide in the US. The recall was initiated on 17 Dec 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Numbers: 602096K089, 602096K090, 602096K091
Quantity recalled184

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0732-2019
FDA event ID
81787
Recalling firm
Meridian Bioscience, Cincinnati, OH
Classification
Class II
Status
Terminated
Recall initiated
17 Dec 2018
FDA classified
14 Jan 2019
Reported
23 Jan 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

17 Dec 2018Recall initiated by company
14 Jan 2019Classified by FDA+28 days
23 Jan 2019Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

An enzyme reagent included in the kit is not maintaining stability through claimed product expiration, resulting in the potential for false negative results when tested with patient specimens and the positive control.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

PREMIER Cryptococcal Antigen, Catalog Number 602096 Product Usage: The PREMIER Cryptococcal Antigen enzyme immunoassay (EIA) is a screening or a semi-quantitative test system for the detection of capsular polysaccharide antigens of Cryptococcus neoformans in serum and cerebrosoinal fluid (CSF).

Where it was distributed

Worldwide Distribution - US Nationwide in the states of: AK, CA, CO, DE, IL, KS, KY, LA, MD, MO, NC, ND, NJ, NY, SC, TX, and VA. The products were distributed to the following foreign countries: India and Italy.

Nationwide AlaskaCaliforniaColoradoDelawareIllinoisKansasKentuckyLouisianaMarylandMissouriNorth CarolinaNorth DakotaNew JerseyNew YorkSouth CarolinaTexasVirginia

Questions about this recall

Why was it recalled?

An enzyme reagent included in the kit is not maintaining stability through claimed product expiration, resulting in the potential for false negative results when tested with patient specimens and the positive control.

Which lots are affected?

Lot Numbers: 602096K089, 602096K090, 602096K091

Where was it sold?

Worldwide Distribution - US Nationwide in the states of: AK, CA, CO, DE, IL, KS, KY, LA, MD, MO, NC, ND, NJ, NY, SC, TX, and VA. The products were distributed to the following foreign countries: India and Italy.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Meridian Bioscience

All 15

Other Test Kits & Diagnostics recalls

All 2,663